Strategies and Challenges to Improve Cellular Programming-Based Approaches for Heart Regeneration Therapy

Lin Jiang,Jialiang Liang,Wei Huang,Zhichao Wu,Christian Paul,Yigang Wang

DOI: https://doi.org/10.3390/ijms21207662

IF: 5.6

2020-10-16

International Journal of Molecular Sciences

Abstract:Limited adult cardiac cell proliferation after cardiovascular disease, such as heart failure, hampers regeneration, resulting in a major loss of cardiomyocytes (CMs) at the site of injury. Recent studies in cellular reprogramming approaches have provided the opportunity to improve upon previous techniques used to regenerate damaged heart. Using these approaches, new CMs can be regenerated from differentiation of iPSCs (similar to embryonic stem cells), the direct reprogramming of fibroblasts [induced cardiomyocytes (iCMs)], or induced cardiac progenitors. Although these CMs have been shown to functionally repair infarcted heart, advancements in technology are still in the early stages of development in research laboratories. In this review, reprogramming-based approaches for generating CMs are briefly introduced and reviewed, and the challenges (including low efficiency, functional maturity, and safety issues) that hinder further translation of these approaches into a clinical setting are discussed. The creative and combined optimal methods to address these challenges are also summarized, with optimism that further investigation into tissue engineering, cardiac development signaling, and epigenetic mechanisms will help to establish methods that improve cell-reprogramming approaches for heart regeneration.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **How to improve the cell - based programming methods to achieve cardiac regenerative therapy, especially by increasing the generation efficiency, functional maturity and safety of cardiomyocytes (CMs)**. Specifically, the paper discusses the following issues:

1. **Limited proliferation ability of adult cardiac cells**:
- After cardiovascular diseases (such as heart failure), the proliferation ability of adult cardiac cells is very limited, resulting in a large loss of cardiomyocytes at the damaged site and hindering heart regeneration.

2. **Limitations of existing technologies**:
- Traditional stem cell transplantation methods (such as mesenchymal stem cells, MSC) have failed to effectively restore the structural and functional integrity of the patient's heart.
- Although certain progress has been made in using induced pluripotent stem cells (iPSCs) and direct reprogramming techniques (such as directly converting fibroblasts into functional cells similar to cardiomyocytes, i.e., induced cardiomyocytes, iCMs), these techniques are still in the early development stage and face many challenges.

3. **Specific challenges**:
- **Inefficiency**: Whether it is iPSCs or direct reprogramming methods, the efficiency of generating cardiomyocytes is still low.
- **Functionally immature**: The generated cardiomyocytes are different from mature adult cardiomyocytes in electrophysiological characteristics, ultrastructure, etc., leading to a potential risk of arrhythmia.
- **Safety issues**: Including the risk of tumor formation, immune rejection, etc.

4. **Future development directions**:
- The paper proposes innovative methods such as tissue engineering, research on cardiac development signaling pathways and epigenetic mechanisms to address the above challenges, aiming to establish more effective cell reprogramming methods to promote the development of cardiac regenerative therapy.

In summary, this paper focuses on how to overcome the key obstacles in cardiac regenerative therapy by improving cell programming methods, thereby providing safer and more effective solutions for clinical applications.